Biotech ETFs Tracking CRISPR Gene Editing Surge
December 21, 2020 at 15:33 PM EST
A biotechnology exchange traded fund focusing on CRISPR gene editing bucked the broader market trends on Monday. Among the best performing non-leveraged ETFs of Monday, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) advanced 7.1%. The ARK Genomic Revolution ETF tracks the convergence of...